MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1259/bjr.20150111

Медицинская библиотека · The British journal of radiology · 2015

The role of stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic disease in the elderly.

Scorsetti Marta, Clerici Elena, Navarria Piera, D'Agostino Giuseppe, Piergallini Lorenzo, De Rose Fiorenza, Ascolese Annamaria, Tozzi Angelo, Iftode Cristina, Villa Elisa, Comito Tiziana, Franzese Ciro, Mancosu Pietro, Tomatis Stefano, Cozzi Luca

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

OBJECTIVE

To report about clinical outcome of stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic disease in elderly patients.

METHODS

Patients with 1-4 inoperable metastases were treated with SBRT. Dose prescription ranged from 40 to 75 Gy in 3-8 fractions. SBRT was delivered using the volumetric modulated arc therapy technique with flattening filter-free photon beams. The primary end points were in-field local control (LC) and toxicity. Secondary end points were overall survival (OS) and disease-specific survival (DSS).

RESULTS

82 patients with 111 total metastases were treated. Median age was 79 years. 64 patients (78%) had a single lesion; the remaining patients had 2-4 lesions. 16 (14.4%) lesions were localized in the abdomen, 50 (45.0%) in the liver and 45 (40.5%) in the lungs. Local response was observed for 87 lesions (78.4%) while local progression was observed in 24 lesions (21.6%). Actuarial 1-year LC was 86.8% ± 3.3%. Actuarial 1-year OS was 93.6% ± 2.7%. 2-year findings were 76.3% ± 4.4% and 72.0% ± 5.6%, respectively. Actuarial 1- and 2-year DSS results were 97.5% ± 2.0% and 81.6% ± 4.9%, respectively. Treatment-related Grade 2-3 toxicity was observed in five patients (4.2%); Grade 1 toxicity in seven patients (5.9%) and no toxicity was observed in 85.4% of the cases.

CONCLUSION

SBRT is a safe and effective therapeutic option for the treatment of oligometastatic disease in the elderly with acceptable rates of LC and low treatment-related toxicity.

ADVANCES IN KNOWLEDGE: The use of SBRT for oligometastatic disease in the elderly can be considered as a valuable approach, particularly for patients with fragile status or refusing other approaches.

Для цитирования: Scorsetti Marta, Clerici Elena, Navarria Piera, D'Agostino Giuseppe, Piergallini Lorenzo, De Rose Fiorenza, Ascolese Annamaria, Tozzi Angelo, Iftode Cristina, Villa Elisa, Comito Tiziana, Franzese Ciro, Mancosu Pietro, Tomatis Stefano, Cozzi Luca. The role of stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic disease in the elderly.. The British journal of radiology. 2015. DOI: 10.1259/bjr.20150111.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.